NABI BIOPHARMACEUTICALS FORM 10-K 12/28/02

Company

Vaxart, Inc.

Filed

February 28, 2003

Period of Report

December 28, 2002

Accession Number

0000950144-03-002477

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →